Article
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Nov 2007
Castaldi L, Serra C, Moretti F, Messina G, Paoletti R, Sampaolesi M, Torgovnick A, Baiocchi M, Padula F, Pisaniello A, Molinaro M, Cossu G, Levrero M, Bouché M
Abstract excerpt
Satellite cells are the main source of myogenic progenitors in postnatal skeletal muscle, but their use in cell therapy for muscle disorders is limited because these cells cannot be delivered through circulation and they are rapidly exhausted in severe myopathies. The search for alternative donor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.